Advertisement

Experimental Models of Lupus Erythematosus

  • Fukumi Furukawa

Keywords

Systemic Lupus Erythematosus Lupus Nephritis Cutaneous Lupus Erythematosus Murine Lupus BXSB Mouse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E (1978) Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 271:67–69CrossRefPubMedGoogle Scholar
  2. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ (1978) Spontaneous murine lupus-like syndrome. Clinical and immunopathological manifestations in several strains. J Exp Med 148:1198–1215CrossRefPubMedGoogle Scholar
  3. Ansel JC, Mountz J, Steinberg AD, DeFabo E, Green J (1985) Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB mice. J Invest Dermatol 85:181–186CrossRefPubMedGoogle Scholar
  4. Appleby P, Webber DG, Bowen JG (1989) Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development. Clin Exp Immunol 78:449–453PubMedGoogle Scholar
  5. Berney T, Fulpius T, Shibata T, Reininger L, Van Snick J, Shan H, Weigert M, Marshak-Rothstein A, Izui S (1992) Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol 4:93–99PubMedGoogle Scholar
  6. Bielschowsky M, Helyer BJ, Howie JB (1959) Spontaneous anemia in mice of the NZB/BL strain. Proc Univ Otago Med Sch 37:9–11Google Scholar
  7. Burrows NP, Bhogal BS, Jones RR, Black MM (1993) Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence. J Cutan Pathol 20:159–162PubMedGoogle Scholar
  8. Dang H, Geiser AG, Letterio JJ, Nakabayashi T, Kong L, Fernandes G, Talal N (1995) SLE-like autoantibodies and Sjogren’s syndrome-like lymphoproliferation in TGF-γ-knockout mice. J Immunol 155:3205–3212PubMedGoogle Scholar
  9. Dauphinee MJ, Kipper SB, Wofsy D, Talal N (1981) Interleukin 2 deficiency is a common feature of autoimmune mice. J Immunol 127:2483–2487PubMedGoogle Scholar
  10. Davis P, Percy JS (1978) Effect of ultraviolet light on disease characteristics of NZB/W mice. J Rheumatol 5:125–128PubMedGoogle Scholar
  11. Drake CG, Babcock SK, Palmer E, Kotzin BL (1994) Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB×NZW)F1 mice. Proc Natl Acad Sci USA 91:4062–4066PubMedGoogle Scholar
  12. Duchosal MA, McConahey PJ, Robinson CA, Dixon FJ (1990) Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med 172:985–988CrossRefPubMedGoogle Scholar
  13. Emerit I(19 82) Chromosome breakage factors: origin and possible significance. Proc Muta Res 4:61–74Google Scholar
  14. Epstein JH, Tuffanelli DL, Dubois EL (1965) Light sensitivity and lupus erythematosus. Arch Dermatol 91:483–485CrossRefPubMedGoogle Scholar
  15. Finck BK, Chan B, Wofsy D (1994) Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 94:585–591PubMedGoogle Scholar
  16. Finck BK, Linsley PS, Wofsy D (1994) Treatment of murine lupus with CTLA4Ig. Science 265:1225–1227PubMedGoogle Scholar
  17. Furukawa F (1997) Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity. Lupus 6:193–202PubMedGoogle Scholar
  18. Furukawa F(1999) Anti-nuclear antibody-keratinocyte interaction in photosensitive cutaneous lupus erythematosus. Histol Histopathol 14:627–63Google Scholar
  19. Furukawa F, Hamashima Y (1982) Lupus band test in New Zealand mice and MRL mice. J Dermatol 9:467–471PubMedGoogle Scholar
  20. Furukawa F, Tanaka H, Sekita K, Nakamura T, Horiguchi Y, Hamashima Y (1984) Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res 276:186–194CrossRefPubMedGoogle Scholar
  21. Furukawa F, Kohno A, Ohshio G, Suzuki K, Hamashima Y (1985a) Pathogenesis of lupus dermatoses in autoimmune mice. IV. Association between cutaneous immunoglobulin deposition and anti-single-stranded DNA antibodies in sera. Arch Dermatol Res 277:79–83CrossRefPubMedGoogle Scholar
  22. Furukawa F, Maruyama N, Yoshida H, Hamashima Y, Hirose S (1985b) Genetic studies on the skin lupus band test in New Zealand mice. Clin Exp Immunol 59:146–152PubMedGoogle Scholar
  23. Furukawa F, Horiguchi Y, Kanauchi Y, Hamashima Y, Imamura S (1986a) The uterus lupus band test and its correlation with the skin lupus band test in autoimmune mice. Microbiol Immunol 30:395–400PubMedGoogle Scholar
  24. Furukawa F, Imamura S, Horiguchi Y et al (1986b) New horizons in murine lupus dermatoses. Proc Jpn Soc Invest Dermatol 10:57–62Google Scholar
  25. Furukawa F, Ohshio G, Tanaka H, Nakamura T, Ikehara S, Imamura S, Hamashima Y (1986c) Pathogenesis of lupus dermatoses in autoimmune mice. VI. Correlation between positivity of lupus band test and lupus nephritis. Arch Dermatol Res 278:343–346CrossRefPubMedGoogle Scholar
  26. Furukawa F, Lyons MB, Norris DA (1989) Susceptible cytotoxicity to ultraviolet B light in fibroblasts and keratinocytes cultured from autoimmune-prone MRL/Mp-lpr/lpr mice. Clin Immunol Immunopathol 52:460–472CrossRefPubMedGoogle Scholar
  27. Furukawa F, Ikai K, Matsuyoshi N, Shimizu K, Imamura S (1993a) Relationship between heat shock protein induction and the binding of antibodies to the extractable nuclear antigens on cultured human keratinocytes. J Invest Dermatol 101:191–195CrossRefPubMedGoogle Scholar
  28. Furukawa F, Ohshio G, Imamura S (1993b) Pathogenesis of lupus dermatoses in autoimmune mice. XIX. Attempts to induce subepidermal immunoglobulin deposition in MRL/Mp+/+mice. Arch Dermatol Res 285:20–26CrossRefPubMedGoogle Scholar
  29. Furukawa F, Kanauchi H, Imamura S (1994) Susceptibility to UVB light in cultured keratinocytes of cutaneous lupus erythematosus. Dermatology 189 (Suppl 1):18–23Google Scholar
  30. Furukawa F, Imamura S, Takigawa M (1995) FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. Arch Dermatol Res 287:558–563CrossRefPubMedGoogle Scholar
  31. Furukawa F, Kanauchi H, Wakita H, Tokura Y, Tachibana T, Horiguchi Y, Imamura S, Ozaki S, Takigawa M (1996) Spontaneous autoimmune skin lesions of MRL/n mice — autoimmune disease-prone genetic background in relation to Fas-defect MRL/lpr mice. J Invest Dermatol 107: 95–100Google Scholar
  32. Galoppin L, Saurat JH (1981) In vitro study of the binding of antiribonucleoprotein antibodies to the nucleus of isolated living keratinocytes. J Invest Dermatol 76:264–267CrossRefPubMedGoogle Scholar
  33. Gelpi C, Rodriguez-Sanchez JL, Martinez MA, Craft J, Hardin JA (1988) Murine graft vs host disease. A model for study of mechanisms that generate autoantibodies to ribonucleoproteins. J Immunol 140:4160–4166PubMedGoogle Scholar
  34. Ghate JV, Turner ML, Rudek MA, Figg WD, Dahut W, Dyer V, Pluda JM, Reed E(2001) Drug-induced lupus associated with COL-3. J Am Acad Dermatol 137:471–474Google Scholar
  35. Gilkeson GS, Spurney R, Coffman TM, Kurlander R, Ruiz P, Piestsky DS (1992) Effectof anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice. Clin Immunol Immunopathol 64:166–172CrossRefPubMedGoogle Scholar
  36. Gilliam JN, Hurd ER, Ziff M (1975) Subepidermal deposition of immunoglobulin in NZB/NZW F1 hybrid mice. J Immunol 114:33–137Google Scholar
  37. Girardi M, Herreid P, Tigelaar RE (1995) Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes. J Invest Dermatol 104:177–182CrossRefPubMedGoogle Scholar
  38. Gleichmann E, Van Elven EH, Van der Veen JPW (1982) A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12:152–159PubMedGoogle Scholar
  39. Golan DT, Borel Y (1984) Increased phtosensitivity to near-ultraviolet light in murine SLE. J Immunol 132:705–710PubMedGoogle Scholar
  40. Halpern B, Emerit I, Housset E(197 2) Possible autoimmune processes related to chromosomal abnormalities (breakage) in NZB mice. Nature 235:214–215Google Scholar
  41. Hiroi A, Ito T, Furukawa F(2001) Immunopathological study on alopecia of the NZB/KN mouse. J Wakayama Med Soc 52:377–383Google Scholar
  42. Horiguchi Y, Furukawa F, Hamashima Y, Imamura S (1984) Ultrastructural observations of skin lesions in MRL mice — dermoepidermal junction. Arch Dermatol Res 276:229–234PubMedGoogle Scholar
  43. Horiguchi Y, Furukawa F, Imamura S (1986a) Ultrastructural observations of skin lesions in MRL mice — dermal infiltrations and capillary changes. J Dermatol 6:440–447Google Scholar
  44. Horiguchi Y, Furukawa F, Hamashima Y, Imamura S (1986b) Ultrastructural lupus band test in skin of MRL/l mice. Arch Dermatol Res 278:474–480CrossRefPubMedGoogle Scholar
  45. Horiguchi Y, Furukawa F, Kanauchi H, Imamura S (1987a) Comparative electron and immunoelectron microscopic studies on immunoglobulin deposits in the glomeruli of the kidney, skin, esophagus and uterus of MRL/l mice. Acta Histochem Cytochem 20:217–227Google Scholar
  46. Horiguchi Y, Furukawa F, Ohshio G, Horio T, Imamura S (1987b) Effects of ultraviolet light irradiation on the skin of MRL/l mice. Arch Dermatol Res 279:478–483CrossRefPubMedGoogle Scholar
  47. Howie JB, Helyer BJ (1968) The immunology and pathology of NZB mice. Adv Immunol 9:215–266PubMedGoogle Scholar
  48. Imamura S (1981)Skinlesion of SLE and its pathomechanisms. Nishinihon J Dermatol 43:1119–1125 (in Japanese)Google Scholar
  49. Ito T, Seo N, Yagi H, Ohtani T, Tokura Y, Takigawa M, Furukawa F (2002) Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 balance of the autoimmunity of MRL/lpr mice. J Dermatol Sci 28:198–210CrossRefPubMedGoogle Scholar
  50. Izui S, Merino R, Iwamoto M, Fossati L(1994) Mechanisms of genetic control of murine systemic lupus erythematosus. Springer Semin Immunopathol 16:133–152CrossRefPubMedGoogle Scholar
  51. Kanauchi H, Furukawa F, Imamura S (1991) Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J Invest Dermatol 96:478–483CrossRefPubMedGoogle Scholar
  52. Kanauchi H, Imamura S, Takigawa M, Furukawa F (1994a) Effects of cyclosporin A on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. J Dermatol Treat 5:187–191Google Scholar
  53. Kanauchi H, Imamura S, Takigawa M, Furukawa F (1994b) Evaluation of the Japanese-Chinese herbal medicine, Kampo, for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice. J Dermatol 21:935–939PubMedGoogle Scholar
  54. Kitajima T, Furukawa F, Kanauchi H, Imamura S, Ogawa K, Sugiyama T (1992) Histological detection of c-myb and c-myc proto-oncogene expression in infiltrating cells in cutaneous lupus erythematosus-like lesions of MRL/l mice by in situ hybridization. Clin Immunol Immunopathol 62:119–123CrossRefPubMedGoogle Scholar
  55. Klinman DM, Steinberg AD (1995) Inquiry into murine and human lupus. Immunol Rev 144:157–193PubMedGoogle Scholar
  56. Kochevar IE (1985) Action spectrum and mechanisms of UV radiation-induced injury in lupus erythematosus. J Invest Dermatol 85:140S–143SCrossRefPubMedGoogle Scholar
  57. Kondo K, Nagami T, Teramoto S (1969) Differences in hematopoietic death among inbred strains of mice. In: Bond PV, Sugahara T (eds) Comparative cellular and species radiosensitivity. Igakushoin, Tokyo, pp 20–29Google Scholar
  58. Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN (1994) Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 91: 10168–10172PubMedGoogle Scholar
  59. Maeda T, Nomoto K (1995) Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels. J Rheumatol 22:2259–2265PubMedGoogle Scholar
  60. Maruyama N, Furukawa F, Nakai Y, Sasaki Y, Ohta K, Ozaki S, Hirose S, Shirai T (1983) Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB×NZW) F1 hybrid and the correlation to renal disease. J Immunol 130:740–746PubMedGoogle Scholar
  61. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C (1997) Development of atopic dermatitis-like skin lesion with IgE hyper-production in NC/Nga mice. Int Immunol 9:461–466CrossRefPubMedGoogle Scholar
  62. Merino R, Iwamoto M, Gershwin ME, Izui S (1994) The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB×BXSB)F1 hybrid mice. J Clin Invest 94:521–525PubMedGoogle Scholar
  63. Mongey AB, Hess EV (1996) Lupus-like syndrome related to drugs and environmental factors. In: Schur PH (ed) the clinical management of systemic lupus erythematosus. Lip pincott Raven, Philadelphia, pp 183–193Google Scholar
  64. Murphy ED, Roths JB (1978) Autoimmunity and lymphoproliferation. Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Bigazzi PE, Warner NL (eds) Genetic control of autoimmune disease. Elsevier, New York,pp 207–221Google Scholar
  65. Nakamura K, Kashiwazaki S, Takagishi K, Tsukamoto Y, Morohoshi Y, Nakano T, Kimura M (1991) Spontaneous degenerative polyarthritis in male New Zealand Black/KN mice. Arthritis Rheum 34:171–179PubMedGoogle Scholar
  66. Natali PG, Mottolese M, Nicotra M (1978) Immune complex formation in NZB/W mice after ultraviolet radiation. Clin Immunol Immunopathol 10:414–419CrossRefPubMedGoogle Scholar
  67. Natali PG, Tan EM (1973) Experimental skin lesions in mice resembling systemic lupus erythematosus. Arthritis Rheum 16:579–589PubMedGoogle Scholar
  68. Oyaizu N, Yasumizu R, Miyama-Inaba M, Nomura S, Yoshida H, Miyawaki S, Shibata Y, Mitsuoka S, Yasunaga K, Morii S et al (1988) (NZW×BXSB) F1 mouse. a new animal model of idiopathic thrombocytopenic purpura. J Exp Med 167:2017–2022PubMedGoogle Scholar
  69. McGrath H Jr (1994) Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 12:129–135PubMedGoogle Scholar
  70. Monestier M, Kandiah DA, Kouts S, Novick KE, Ong GL, Radic MZ, Krilis SA (1996) Monoclonal antibodies from NZW×BXSB F1 mice to β2-glycoprotein I and cardiolipin. J Immunol 156:2631–2641PubMedGoogle Scholar
  71. Nishimura H, Honjo T (2001) PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 22:265–268CrossRefPubMedGoogle Scholar
  72. Provost TT, Watson R (1993) The MRL/lpr mouse model of cutaneous lupus. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus, 4th ed. Lea & Febiger, Baltimore, p 282Google Scholar
  73. Reddy AL, Fialkow PJ, Salo A (1978) Ultraviolet radiation-induced chromosomal abnormalities in fetal fibroblasts from New Zealand black mice. Science 201:920–922PubMedGoogle Scholar
  74. Reininger L, Radaszkiewicz T, Kosco M, Melchers F, Rolink AG (1992) Development of autoimmune disease in SCID mice populated with long-term “in vitro” proliferating (NZB×NZW)F1 pre-B cells. J Exp Med 176:1343–1353CrossRefPubMedGoogle Scholar
  75. Rook GAW, Ristori G, Salvetti M, Giovannoni G, Thompson EJ, Standford JL (2000) Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune diseases. Immunol Today 21:503–507CrossRefPubMedGoogle Scholar
  76. Satoh M, Richards HB, Reeves WH (1999) Pathogenesis of autoantibody production and glomerulonephritis in pristane-treated mice. In: Kammer GM, Tsokos GC (eds) Lupus molecular and cellular pathogenesis. Humana Press, Totowa, NJ, pp399–416Google Scholar
  77. Segal R, Globerson A, Zinger H, Mozes E (1992) Induction of experimental systemic lupus erythematosus (SLE) in mice with severe combined immunodeficiency (SCID). Clin Exp Immunol 89:239–243PubMedGoogle Scholar
  78. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S (2002) Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol 3:135–142CrossRefGoogle Scholar
  79. Shirai T (1982) The genetic basis of autoimmunity in murine lupus. Immunol Today 7:187–194Google Scholar
  80. Shirai T, Ohta K, Kohno A, Furukawa F, Yoshida H, Maruyama N, Hirose S (1986) Naturally occurring antibody response to DNA is associated with the response to retroviral gp70 in autoimmune New Zealand mice. Arthritis Rheum 29:242–250PubMedGoogle Scholar
  81. Shoenfeld Y (1994) Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome. Transplant Proc 26:3211–3213PubMedGoogle Scholar
  82. Sneller MC, Straus SE, Jaffe ES, Fleisher TA, Stetler-Stevenson M, Strober W (1992) A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334–341PubMedGoogle Scholar
  83. Sontheimer RD (1996) Photoimmunologyof lupus erythematosus and dermatomyositis: a speculative review. Photochem Photobiol 63:583–594PubMedGoogle Scholar
  84. Sontheimer RD, Gilliam JN (1979) Regional variation in the deposition of subepidermal immunoglobulin in NZB/W F1 mice: associationwith epidermal DNA synthesis. J Invest Dermatol 72:25–28PubMedGoogle Scholar
  85. Steinberg AD (1995) Insights into the basis of systemic lupus. J Autoimmunity 8:771–785Google Scholar
  86. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S (1996) Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 97:1597–1604PubMedGoogle Scholar
  87. Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M (1991 ) IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 147:515–519PubMedGoogle Scholar
  88. Tamada Y, Ohhashi M, Kobayashi T et al (1976) Pathological studies on NC mouse with erythema and alopecia. Jpn J Allergol 25:829–836Google Scholar
  89. Taneja V, David CS (2001) Lessons from animal models for human autoimmune diseases. Nature Immunol 2:781–784Google Scholar
  90. Tang B, Matsuda M, Akira S, Nagata N, Ikehara S, Hirano T, Kishimoto T (1991) Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 3:273–278PubMedGoogle Scholar
  91. Theofilopoulos AN (1995) The basis of autoimmunity. 2. Genetic predisposition. Immunol Today 6:150–159Google Scholar
  92. Theofilopoulos AN, Dixon FJ (1981) Etiopathogenesis of murine SLE. Immunol Rev 55:179–216PubMedGoogle Scholar
  93. Van Rappard-Van Der Veen FM, Radaszkiewicz R, Terraneo L, Gleichmann E (1983) Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. J Immunol 130:2693–2701PubMedGoogle Scholar
  94. Vladutiu AO (1993) The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol 93:1–8PubMedGoogle Scholar
  95. Velthuis PJ, Kater L, van der Tweel I, Meyling FG, Derksen RH, Hene RJ, van Geutselaar JA, Baart de la Faille H (1990) In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies. Ann Rheum Dis 49:163–167PubMedGoogle Scholar
  96. Vidal S, Gelpi C, Rodriguez-Sanchez JL (1994) (SWR×SJL)F1 mice: a new model of lupus-like disease. J Exp Med 179:1429–1435CrossRefPubMedGoogle Scholar
  97. Wandstract A, Wakeland E (2001) The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nature Immunol 2:802–809CrossRefGoogle Scholar
  98. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314–317CrossRefPubMedGoogle Scholar
  99. Yoshimasu T, Hiroi A, Ohtani T, Furukawa F (2001a) Establishment of a model for drug induced discoid lupus erythematosus in TCR alpha chain knockout mouse. Exp Dermatol 10:213CrossRefGoogle Scholar
  100. Yoshimasu T, Hiroi A, Uede K, Furukawa F (2001b) Discoid lupus erythematosus(DLE)-like lesion induced by uracil-tegafur(UFT). Eur J Dermatol 11:54–57PubMedGoogle Scholar
  101. Yoshimasu T, Nishide T, Seo N, Hiroi A, Ohtani T, Uede K, Furukawa F (2004) Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus. Clin Exp Immunol 136:245–254CrossRefPubMedGoogle Scholar
  102. Zamanski GB, Kleinman LF, Kaplan JC, Black PH (1980) Effect of ultraviolet light irradiation on the survival of New Zealand black mouse cells. Arthritis Rheum 23:866–867PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 2005

Authors and Affiliations

  • Fukumi Furukawa

There are no affiliations available

Personalised recommendations